Autolus Therapeutics (AUTL) Misses Q3 EPS by 1c

Autolus Therapeutics (NASDAQ: AUTL) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Autolus Therapeutics (AUTL) click here.

You May Also Be Interested In

• Autolus Therapeutics to Participate in Upcoming Investor Conference
• Mistras Group expands Houston lab for aerospace and defense work
• BlackBerry surges on earnings beat and strong cash flow